Virax Biolabs【VRAX】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.30

買値

1.85

売値

2.45

出来高

266,655

2.11 日の範囲 2.33

0.60 52 週間の範囲 8.9999

時価総額

9.982M

前日終値

2.14

始値

2.30

時刻

2.3

最終取引時間

財務取引量

US$ 595,214

VWAP

2.2321

平均取引量 (3 か月)

389,229

発行済株式数

4,340,000

配当利回り

PER

-1.41

1 株当たり利益 (EPS)

-1.55

歳入

156k

純利益

-6.73M

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunolo... Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. 詳細を表示

セクター

In Vitro,in Vivo Diagnostics

業界

In Vitro,in Vivo Diagnostics

ウェブサイト

viraxbiolabs.com

本社

Oxon, Gbr

設立

Virax Biolabs Group Ltd is listed in the In Vitro,in Vivo Diagnostics sector of the ナスダック市場 with ticker VRAX. The last closing price for Virax Biolabs was US$2.14. Over the last year, Virax Biolabs shares have traded in a share price range of US$ 0.60 to US$ 8.9999.

Virax Biolabs currently has 4,340,000 shares in issue. The market capitalisation of Virax Biolabs is US$9.29 million. Virax Biolabs has a price to earnings ratio (PE ratio) of -1.41.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs' CEO James Foster Issues Letter to Shareholders PR Newswire LONDON, Dec. 17, 2024 LONDON, Dec. 17, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland PR Newswire LONDON, Dec. 10, 2024 LONDON, Dec. 10, 2024...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland PR Newswire LONDON, Oct. 23, 2024 LONDON, Oct. 23, 2024...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.08	-3.36134453782	2.38	2.61	1.85	243389	2.24301608	CS
4	0.51	28.4916201117	1.79	3.2	1.62	543923	2.43270921	CS
12	-0.25	-9.80392156863	2.55	3.2	1.5143	389229	2.25534566	CS
26	1.06	85.4838709677	1.24	8.9999	0.9541	3217180	4.13542155	CS
52	1.27	123.300970874	1.03	8.9999	0.6	2012169	3.70848372	CS
156	-197.7	-98.85	200	290	0.6	1509077	21.75346737	CS
260	-197.7	-98.85	200	290	0.6	1509077	21.75346737	CS

VRAX - Frequently Asked Questions (FAQ)

What is the current Virax Biolabs share price?

The current share price of Virax Biolabs is US$ 2.30

How many Virax Biolabs shares are in issue?

Virax Biolabs has 4,340,000 shares in issue

What is the market cap of Virax Biolabs?

The market capitalisation of Virax Biolabs is USD 9.29M

What is the 1 year trading range for Virax Biolabs share price?

Virax Biolabs has traded in the range of US$ 0.60 to US$ 8.9999 during the past year

What is the PE ratio of Virax Biolabs?

The price to earnings ratio of Virax Biolabs is -1.41

What is the cash to sales ratio of Virax Biolabs?

The cash to sales ratio of Virax Biolabs is 61

What is the reporting currency for Virax Biolabs?

Virax Biolabs reports financial results in USD

What is the latest annual turnover for Virax Biolabs?

The latest annual turnover of Virax Biolabs is USD 156k

What is the latest annual profit for Virax Biolabs?

The latest annual profit of Virax Biolabs is USD -6.73M

What is the registered address of Virax Biolabs?

The registered address for Virax Biolabs is 30 BROADWICK STREET LONDON, W1F 8LX, OXON

What is the Virax Biolabs website address?

The website address for Virax Biolabs is viraxbiolabs.com

Which industry sector does Virax Biolabs operate in?

Virax Biolabs operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

銘柄コード	株価	出来高
BTCTBTC Digital Ltd	US$ 8.2697 (73.73%)	61.45M
BDMDBaird Medical Investment Holdings Ltd	US$ 8.80 (62.36%)	18.63M
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
NUKKNukkleus Inc	US$ 29.97 (45.98%)	19.09M
GSITGSI Technology	US$ 3.97 (44.36%)	87.7M
DOGZDogness International Corporation	US$ 18.23 (-58.77%)	740.45k
ORKTOrangeKloud Technology Inc	US$ 3.02 (-24.88%)	21.08M
PMAXPowell Max Ltd	US$ 0.6364 (-23.31%)	4.17M
LGCBLinkage Global Inc	US$ 0.2876 (-22.27%)	890.66k
YYAIConnexa Sports Technologies Inc	US$ 0.8299 (-20.20%)	602.48k
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
GCTKGlucoTrack Inc	US$ 0.0852 (15.45%)	465.22M
RIMEAlgorhythm Holdings Inc	US$ 0.0406 (-4.02%)	387.23M
TGLTreasure Global Inc	US$ 0.2459 (14.75%)	267.1M
NVDANVIDIA Corporation	US$ 137.71 (3.10%)	201.4M

銘柄コード

株価

出来高